Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.300
+0.010 (0.44%)
At close: Mar 6, 2026, 4:00 PM EST
2.290
-0.010 (-0.43%)
After-hours: Mar 6, 2026, 7:06 PM EST
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $129.58 million as of March 6, 2026. Its market cap has increased by 184.17% in one year.
Market Cap
129.58M
Enterprise Value
84.32M
1-Year Change
184.17%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $129.58M, a decrease of -15.91%. That is a compound annual growth rate of -2.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 129.60M | -1.29% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 140.31M |
| Connect Biopharma Holdings | 138.64M |
| Adagene | 133.85M |
| Oramed Pharmaceuticals | 130.75M |
| Polaryx Therapeutics | 129.72M |
| Cardiff Oncology | 128.53M |
| Aardvark Therapeutics | 127.37M |
| Alpha Cognition | 125.89M |